SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-18-000632
Filing Date
2018-11-13
Accepted
2018-11-13 07:01:08
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10Q spring.htm 10-Q 534194
2 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER exh31_1.htm EX-31.1 9422
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER exh31_2.htm EX-31.2 9488
4 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICE exh_32.htm EX-32 7322
  Complete submission text file 0001096906-18-000632.txt   2005339

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cyig-20180930.xml EX-101.INS 303451
6 XBRL TAXONOMY EXTENSION SCHEMA cyig-20180930.xsd EX-101.SCH 25739
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cyig-20180930_cal.xml EX-101.CAL 30967
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyig-20180930_def.xml EX-101.DEF 25334
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyig-20180930_lab.xml EX-101.LAB 127183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyig-20180930_pre.xml EX-101.PRE 108348
Mailing Address 11 QUANXING ROAD SHANDONG PROVINCE SICHUI F4 273200
Business Address 11 QUANXING ROAD SHANDONG PROVINCE SICHUI F4 273200 86-537-4268278
SPRING PHARMACEUTICAL GROUP, INC. (Filer) CIK: 0000847464 (see all company filings)

IRS No.: 652954561 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53600 | Film No.: 181175006
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1